ImmunityBio gets FDA authorisation to begin trial of novel Covid-19 vaccine candidate

ImmunityBio has secured FDA authorisation to commence clinical trial of novel Covid-19 vaccine candidate. (Credit: Daniel Roberts from Pixabay)